Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 2
2023 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study.
Alexeeva E, Shingarova M, Dvoryakovskaya T, Lomakina O, Fetisova A, Isaeva K, Chomakhidze A, Chibisova K, Krekhova E, Kozodaeva A, Savostyanov K, Pushkov A, Zhanin I, Demyanov D, Suspitsin E, Belozerov K, Kostik M. Alexeeva E, et al. Among authors: fetisova a. Front Med (Lausanne). 2023 Nov 15;10:1257045. doi: 10.3389/fmed.2023.1257045. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034538 Free PMC article.
Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data.
Alexeeva E, Krekhova E, Dvoryakovskaya T, Isaeva K, Chomakhidze A, Chistyakova E, Lomakina O, Denisova R, Mamutova A, Fetisova A, Gautier M, Vankova D, Kriulin I, Saygitov R. Alexeeva E, et al. Among authors: fetisova a. Front Pediatr. 2023 Feb 22;11:1114207. doi: 10.3389/fped.2023.1114207. eCollection 2023. Front Pediatr. 2023. PMID: 36911042 Free PMC article.
Safety and Efficacy of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus Type B Infections in Children with Systemic Juvenile Idiopathic Arthritis: Prospective Cohort Study.
Alexeeva E, Dvoryakovskaya T, Kudlay D, Fetisova A, Kriulin I, Krekhova E, Kabanova A, Labinov V, Labinova E, Kostik M. Alexeeva E, et al. Among authors: fetisova a. Vaccines (Basel). 2025 Jun 15;13(6):644. doi: 10.3390/vaccines13060644. Vaccines (Basel). 2025. PMID: 40573975 Free PMC article.
Can We Successfully Discontinue Anti-Tumor Necrosis Factor-α Treatment in Children with Non-Systemic Juvenile Idiopathic Arthritis? The Experience of a Tertiary Center.
Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kudlay DA, Kriulin IA, Botova MS, Kondratyeva NM, Krekhova EA, Shingarova MS, Kokina MY, Fetisova AN, Isaeva KB, Chomakhidze AM, Chibisova CV, Kostik MM. Alexeeva EI, et al. Among authors: fetisova an. Biomedicines. 2025 Sep 24;13(10):2329. doi: 10.3390/biomedicines13102329. Biomedicines. 2025. PMID: 41153616 Free PMC article.
The Efficacy and Safety of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus influenzae Type b Infections in Children with Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study.
Alexeeva E, Dvoryakovskaya T, Fetisova A, Kriulin I, Krekhova E, Kabanova A, Labinov V, Labinova E, Kostik M. Alexeeva E, et al. Among authors: fetisova a. Vaccines (Basel). 2025 Feb 12;13(2):177. doi: 10.3390/vaccines13020177. Vaccines (Basel). 2025. PMID: 40006724 Free PMC article.
Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare.
Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kriulin IA, Kudlay DA, Fetisova AN, Botova MS, Kriulina TY, Krekhova EA, Kondratyeva NM, Shingarova MS, Kokina MY, Shilova AN, Kostik MM. Alexeeva EI, et al. Among authors: fetisova an. Pharmaceuticals (Basel). 2026 Jan 10;19(1):125. doi: 10.3390/ph19010125. Pharmaceuticals (Basel). 2026. PMID: 41599723 Free PMC article.
Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method.
Alexeeva E, Dvoryakovskaya T, Denisova R, Sleptsova T, Isaeva K, Chomahidze A, Fetisova A, Mamutova A, Alshevskaya A, Gladkikh V, Moskalev A. Alexeeva E, et al. Among authors: fetisova a. Mod Rheumatol. 2019 Sep;29(5):848-855. doi: 10.1080/14397595.2018.1516329. Epub 2019 Jan 3. Mod Rheumatol. 2019. PMID: 30149747
Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
Alexeeva EI, Namazova-Baranova LS, Bzarova TM, Valieva SI, Denisova RV, Sleptsova TV, Isaeva KB, Chomahidze AM, Taibulatov NI, Fetisova AN, Karaseva AV, Baranov AA. Alexeeva EI, et al. Among authors: fetisova an. Pediatr Rheumatol Online J. 2017 Jun 14;15(1):51. doi: 10.1186/s12969-017-0178-9. Pediatr Rheumatol Online J. 2017. PMID: 28615036 Free PMC article.